BCAB

BioAtla, Inc.
NasdaqCMUSDEQUITY DELAYED
Last price
3.27
▲ 0.09 (2.69%)
MARKET ·

Price

Open
3.44
Prev close
3.18
Day high
3.40
Day low
3.03
Volume
83.88K
Market cap
P/E (TTM)
52W range
2.81 – 71.50

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
+2.91% +4.3%
1M
-8.09% -11.8%
3M
-12.03% -15.1%
6M
-62.59% -73.7%
YTD
-88.80% -101.1%
1Y
-83.04% -103.0%
3Y
-97.51% -171.7%
5Y

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported
Market cap
Enterprise value
Revenue (TTM)
Gross profit
EBITDA
Net income
EPS (TTM)
Free cash flow
Total cash
Total debt
Book value / share
Shares outstanding
Float
Short % of float
Dividend yield
Beta (5Y)

Valuation & profitability ratios

Account required
Trailing P/E
Forward P/E
PEG ratio
Price / sales
Price / book
EV / revenue
EV / EBITDA
Gross margin
Operating margin
Profit margin
Return on equity
Return on assets
Debt / equity
Current ratio
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Analyst targets & ownership

Account required
Mean target
High target
Low target
Implied upside
Analyst count
Consensus
Strong buy / Buy— / —
Hold
Sell / Strong sell— / —
Held by insiders
Held by institutions
Institutions holding
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
3.28
-0.32% from price
SMA 20
3.32
-4.08% from price
SMA 50
3.60
-11.68% from price
SMA 100
4.03
-18.98% from price
SMA 200
13.54
-76.52% from price
EMA 12
3.27
-0.06% from price
EMA 26
3.39
-3.79% from price
EMA 50
3.71
-12.00% from price
RSI (14)
42.2
Neutral
MACD (12,26,9)
-0.13
Hist -0.00
ATR (14)
0.31
9.78% of price
Realised vol 30D
66.4%
Annualised
Bollinger upper
3.58
20, 2σ
Bollinger lower
3.05
20, 2σ
50 / 200 cross
Death
3.60 vs 13.54
Trend bias
Below 200
-76.52%

Risk profile

Daily returns · 1Y window
Beta vs SPY
0.39
Less volatile than market
Correlation to SPY
0.04
Largely independent
Realised vol 30D
66.4%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-95.0%
Peak to trough
Max drawdown 5Y
-99.9%
Peak to trough
ATR 14
0.31
9.78% of price
Beta (reported)
5Y monthly, from filing

Options chain

Account required
ExpirySpot 3.27
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.